Published in Nature on November 07, 1991
Peptoids: a modular approach to drug discovery. Proc Natl Acad Sci U S A (1992) 4.08
Encoded combinatorial chemistry. Proc Natl Acad Sci U S A (1992) 4.00
Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet (2000) 3.64
The use of mRNA display to select high-affinity protein-binding peptides. Proc Natl Acad Sci U S A (2001) 2.63
A trap-and-release integrated microfluidic system for dynamic microarray applications. Proc Natl Acad Sci U S A (2007) 2.52
Complex synthetic chemical libraries indexed with molecular tags. Proc Natl Acad Sci U S A (1993) 2.44
The minimum element of a synthetic peptide required to block prostate tumor cell migration. Cancer Biol Ther (2006) 2.20
Generation and screening of an oligonucleotide-encoded synthetic peptide library. Proc Natl Acad Sci U S A (1993) 1.81
An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. Proc Natl Acad Sci U S A (1997) 1.70
Seamless bead to microarray screening: rapid identification of the highest affinity protein ligands from large combinatorial libraries. Chem Biol (2010) 1.67
Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc Natl Acad Sci U S A (1992) 1.52
Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials (2011) 1.50
Degenerate peptide recognition by Candida albicans adhesins Als5p and Als1p. Infect Immun (2004) 1.47
Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers. Nucleic Acids Res (2003) 1.41
Tagged versus untagged libraries: methods for the generation and screening of combinatorial chemical libraries. Proc Natl Acad Sci U S A (1994) 1.40
Direct screening of solution phase combinatorial libraries encoded with externally sensitized photolabile tags. Proc Natl Acad Sci U S A (2006) 1.39
Combinatorial profiling of chromatin binding modules reveals multisite discrimination. Nat Chem Biol (2010) 1.39
Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodies. Proc Natl Acad Sci U S A (2016) 1.39
Peptidomimetics, a synthetic tool of drug discovery. Curr Opin Chem Biol (2008) 1.37
Synthesis and screening of stereochemically diverse combinatorial libraries of peptide tertiary amides. Chem Biol (2013) 1.32
Protein-peptide interactions analyzed with the yeast two-hybrid system. Nucleic Acids Res (1995) 1.31
Combinatorial evolution of site- and enantioselective catalysts for polyene epoxidation. Nat Chem (2012) 1.29
Identification of highest-affinity ligands by affinity selection from equimolar peptide mixtures generated by robotic synthesis. Proc Natl Acad Sci U S A (1992) 1.26
On-bead screening of combinatorial libraries: reduction of nonspecific binding by decreasing surface ligand density. J Comb Chem (2009) 1.26
Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob Agents Chemother (2005) 1.25
Screening bicyclic peptide libraries for protein-protein interaction inhibitors: discovery of a tumor necrosis factor-α antagonist. J Am Chem Soc (2013) 1.24
Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library. Proc Natl Acad Sci U S A (1993) 1.21
Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Curr Pharm Des (2010) 1.20
Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. Nucleic Acids Res (2002) 1.16
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein. J Mol Biol (2008) 1.14
The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc Natl Acad Sci U S A (1997) 1.12
Incorporation of heterocycles into the backbone of peptoids to generate diverse peptoid-inspired one bead one compound libraries. ACS Comb Sci (2012) 1.11
High-throughput sequencing of peptoids and peptide-peptoid hybrids by partial edman degradation and mass spectrometry. J Comb Chem (2009) 1.11
The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs. Int J Pept Res Ther (2006) 1.11
Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents. Antimicrob Agents Chemother (1996) 1.11
SIRT1 top 40 hits: use of one-bead, one-compound acetyl-peptide libraries and quantum dots to probe deacetylase specificity. Biochemistry (2006) 1.11
Characterization of oligodeoxyribonucleotide synthesis on glass plates. Nucleic Acids Res (2001) 1.11
Portion-mixing peptide libraries of quenched fluorogenic substrates for complete subsite mapping of endoprotease specificity. Proc Natl Acad Sci U S A (1994) 1.11
Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method. J Med Chem (2009) 1.10
Utility of redundant combinatorial libraries in distinguishing high and low quality screening hits. ACS Comb Sci (2014) 1.10
Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1. J Am Chem Soc (2011) 1.08
Protein N-terminal processing: substrate specificity of Escherichia coli and human methionine aminopeptidases. Biochemistry (2010) 1.08
Identification of highly reactive sequences for PLP-mediated bioconjugation using a combinatorial peptide library. J Am Chem Soc (2010) 1.07
PCR amplification from single DNA molecules on magnetic beads in emulsion: application for high-throughput screening of transcription factor targets. Nucleic Acids Res (2005) 1.07
Discovery of peptoid ligands for anti-aquaporin 4 antibodies. Chem Biol (2013) 1.07
Acyl hydrazides as peptoid sub-monomers. Chem Commun (Camb) (2011) 1.07
Combinatorial peptide libraries: mining for cell-binding peptides. Chem Rev (2013) 1.07
Synthesis of libraries of peptidomimetic compounds containing a 2-oxopiperazine unit in the main chain. Org Biomol Chem (2013) 1.05
Organic chemistry and biology: chemical biology through the eyes of collaboration. J Org Chem (2009) 1.05
Discovering ligands for a microRNA precursor with peptoid microarrays. Nucleic Acids Res (2009) 1.04
Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach. Urol Oncol (2010) 1.04
Acetalins: opioid receptor antagonists determined through the use of synthetic peptide combinatorial libraries. Proc Natl Acad Sci U S A (1993) 1.03
One-bead-one-catalyst approach to aspartic acid-based oxidation catalyst discovery. ACS Comb Sci (2011) 1.03
Design and development of molecular imaging probes. Curr Top Med Chem (2010) 1.02
The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library. Proc Natl Acad Sci U S A (1994) 1.02
Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. J Med Chem (2009) 1.02
The synthesis of blocked triplet-phosphoramidites and their use in mutagenesis. Nucleic Acids Res (1995) 1.01
A combined atomic force/fluorescence microscopy technique to select aptamers in a single cycle from a small pool of random oligonucleotides. Microsc Res Tech (2007) 1.01
Rethinking screening. Nat Chem Biol (2010) 1.01
Histones: at the crossroads of peptide and protein chemistry. Chem Rev (2014) 1.01
Induction of humoral immune response against Plasmodium falciparum sporozoites by immunization with a synthetic peptide mimotope whose sequence was derived from screening a filamentous phage epitope library. Infect Immun (1995) 1.00
High-throughput synthesis and screening of cyclic peptide antibiotics. J Med Chem (2007) 0.99
Mapping protein-protein interactions by affinity-directed mass spectrometry. Proc Natl Acad Sci U S A (1996) 0.99
A combinatorial H4 tail library for exploring the histone code. Biochemistry (2008) 0.99
High-throughput screening of one-bead-one-compound libraries: identification of cyclic peptidyl inhibitors against calcineurin/NFAT interaction. ACS Comb Sci (2011) 0.99
Creation and functional screening of a multi-use peptide library. Proc Natl Acad Sci U S A (1994) 0.98
Thymidine kinase mutants obtained by random sequence selection. Proc Natl Acad Sci U S A (1993) 0.97
Controlled formation of peptide bonds in the gas phase. J Am Chem Soc (2011) 0.97
Recursive deconvolution of combinatorial chemical libraries. Proc Natl Acad Sci U S A (1994) 0.96
Identification of antimicrobial peptides by using combinatorial libraries made up of unnatural amino acids. Antimicrob Agents Chemother (1994) 0.96
Histone tails: ideal motifs for probing epigenetics through chemical biology approaches. Chembiochem (2010) 0.95
Potential pharmacological chaperones targeting cancer-associated MCL-1 and Parkinson disease-associated α-synuclein. Proc Natl Acad Sci U S A (2014) 0.95
Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA. ACS Chem Biol (2011) 0.95
Synthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptor. Bioorg Med Chem (2008) 0.95
"Libraries from libraries": chemical transformation of combinatorial libraries to extend the range and repertoire of chemical diversity. Proc Natl Acad Sci U S A (1994) 0.95
Discovery of native autoantigens via antigen surrogate technology: application to type 1 diabetes. ACS Chem Biol (2014) 0.95
The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle. Mol Cancer Ther (2010) 0.95
Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries. Immunogenetics (2004) 0.94
Cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther (Seoul) (2012) 0.94
Novel peptide ligands of RGS4 from a focused one-bead, one-compound library. Chem Biol Drug Des (2008) 0.94
Inhibition of MMP-2 gelatinolysis by targeting exodomain-substrate interactions. Biochem J (2007) 0.93
Synthetic receptors with antibody-like binding affinities. Curr Opin Chem Biol (2010) 0.93
Submonomer synthesis of a hybrid peptoid-azapeptoid library. ACS Comb Sci (2012) 0.93
A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response. J Virol (1995) 0.93
Protein and Chemical Microarrays-Powerful Tools for Proteomics. J Biomed Biotechnol (2003) 0.93
Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry. Antimicrob Agents Chemother (1998) 0.93
DNA-Encoded Solid-Phase Synthesis: Encoding Language Design and Complex Oligomer Library Synthesis. ACS Comb Sci (2015) 0.92
Identification and mapping of linear antibody epitopes in human serum albumin using high-density Peptide arrays. PLoS One (2013) 0.92
Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting alpha 3 integrin. Eur J Nucl Med Mol Imaging (2008) 0.92
Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2. Virol J (2009) 0.92
Defining SH2 domain and PTP specificity by screening combinatorial peptide libraries. Methods (2007) 0.92
Screening small-molecule compound microarrays for protein ligands without fluorescence labeling with a high-throughput scanning microscope. J Biomed Opt (2010) 0.92
Liquid-phase combinatorial synthesis. Proc Natl Acad Sci U S A (1995) 0.92
Biotin-tagged cDNA expression libraries displayed on lambda phage: a new tool for the selection of natural protein ligands. Nucleic Acids Res (2002) 0.91
Investigation of antigen-antibody interactions using a soluble, non-support-bound synthetic decapeptide library composed of four trillion (4 x 10(12) sequences. Biochem J (1994) 0.90
A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization. Immunology (2000) 0.90
Optimizing doped libraries by using genetic algorithms. J Comput Aided Mol Des (1997) 0.90
Codon-based mutagenesis using dimer-phosphoramidites. Nucleic Acids Res (1998) 0.90
Decoding split and pool combinatorial libraries with electron-transfer dissociation tandem mass spectrometry. J Am Soc Mass Spectrom (2013) 0.89
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med (2001) 11.73
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer (1975) 10.04
Primary bioassay of human tumor stem cells. Science (1977) 9.69
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (1997) 6.80
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med (1978) 5.78
High speed scintillation autoradiography. Science (1975) 5.15
Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes. J Immunol (1968) 4.25
The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J Immunol (1968) 4.24
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis (1983) 3.86
Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med (1965) 3.54
Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A (1983) 3.17
Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med (1974) 2.97
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol (1989) 2.89
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A (1980) 2.80
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis (1985) 2.64
The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation. Clin Exp Immunol (1970) 2.40
Primary bioassay of human myeloma stem cells. J Clin Invest (1977) 2.25
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study. Blood (1990) 2.24
Direct cloning of human ovarian carcinoma cells in agar. Cancer Res (1978) 2.24
Activation of two signal-transduction systems in hepatocytes by glucagon. Nature (1986) 2.21
Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J Clin Invest (1970) 2.21
B-cell neoplasia in man. Lancet (1974) 2.11
Prevention of doxorubicin-induced hair loss with scalp hypothermia. N Engl J Med (1979) 1.94
Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA (1991) 1.93
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med (1980) 1.91
"Sandwich" solid phase radioimmunoassay for the quantitative deterimination of human immunoglobulins. J Immunol (1969) 1.74
Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. N Engl J Med (1990) 1.72
Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology (1991) 1.67
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst (1995) 1.67
Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci (2001) 1.67
Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis (1984) 1.67
Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet (1973) 1.66
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J Clin Oncol (1991) 1.64
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med (1973) 1.57
Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. J Clin Oncol (1996) 1.57
Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med (1984) 1.57
Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem (1989) 1.54
Cancer immunotherapy. Can Med Assoc J (1979) 1.54
Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions. Br J Cancer (1980) 1.52
Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res (1977) 1.52
Dose response evaluation of adriamycin in human neoplasia. Cancer (1977) 1.51
Preparation of permanent slides of intact soft-agar colony cultures of hematopoietic and tumor stem cells. Cancer Res (1979) 1.51
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther (1984) 1.45
Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Cancer Drug Deliv (1983) 1.43
Myeloperoxidase deficiency. Immunologic study of a genetic leukocyte defect. N Engl J Med (1970) 1.41
Immunomorphological features of prognostic significance in Dukes' Class B colorectal carcinoma. Cancer Res (1977) 1.40
The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer. J Natl Cancer Inst (1977) 1.40
Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study. Blood (1991) 1.40
Cells capable of colony formation in the peripheral blood of man. Science (1971) 1.40
Immunology of the lower respiratory tract. II. The plaque-forming response of canine lymphoid tissues to sheep erythrocytes after intrapulmonary or intravenous immunization. J Clin Invest (1974) 1.39
Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer (1975) 1.39
Kinetics of tumor growth and regression in IgG multiple myeloma. J Clin Invest (1972) 1.38
GM-CSF, carboplatin, doxorubicin: a phase I study. Cancer Chemother Pharmacol (1994) 1.38
Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med (1971) 1.38
Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides (1991) 1.37
Hormonal regulation of Gi2 alpha-subunit phosphorylation in intact hepatocytes. Biochem J (1990) 1.37
Sensitivity- and gradient-enhanced hetero (omega1) half-filtered TOCSY experiment for measuring long-range heteronuclear coupling constants. J Magn Reson (1998) 1.34
Molecular biology and pharmacology of cloned opioid receptors. FASEB J (1995) 1.34
Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proc Natl Acad Sci U S A (1994) 1.32
Antigen dose in the human immune response. Dose-relationships in the human immune response to Keyhole limpet hemocyanin. J Lab Clin Med (1971) 1.32
Conformational restrictions of biologically active peptides via amino acid side chain groups. Life Sci (1982) 1.32
Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions. Biophys J (2000) 1.32
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther (1995) 1.30
Human tumor colony assay and chemosensitivity testing. Cancer Treat Rep (1984) 1.30
Immunoglobulin synthesis and tumour cell number and the natural history of multiple myeloma. Br Med J (1971) 1.30
Pulmonary complications of acute leukemia. Cancer (1966) 1.30
Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Br J Pharmacol (2010) 1.30
Immunological characterization of homosexual males. Cancer Res (1983) 1.29
Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis. Cancer (1971) 1.29
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages. N Engl J Med (1982) 1.27
Application of a human tumor colony-forming assay to new drug screening. Cancer Res (1985) 1.26
Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol (1987) 1.26
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Biological and conformational study of beta-substituted prolines in MT-II template: steric effects leading to human MC5 receptor selectivity. J Pept Res (2004) 1.25
D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J Med Chem (2000) 1.25
Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. J Med Chem (1986) 1.24
Skin reactivity in patients with cancer. Impaired delayed hypersensitivity or faulty inflammatory response? N Engl J Med (1971) 1.24
Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. Cancer Res (1984) 1.23
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol (1998) 1.23
Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors. Proc Natl Acad Sci U S A (1996) 1.23
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro. J Natl Cancer Inst (1992) 1.23
Lymphocyte activation: a rapid test to predict allograft rejection. Nature (1970) 1.22
Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. Science (1986) 1.22
Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J Neurosci (1996) 1.22
Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment. Biochem Pharmacol (1976) 1.21
Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol (1997) 1.20
Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science (1982) 1.18
Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood (1980) 1.18
Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Semin Hematol (1973) 1.17
Hepatotoxic effects of methotrexate. Cancer (1966) 1.17
Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Res (1990) 1.16
Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity. Life Sci (1992) 1.16
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Blood (1993) 1.16
Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. Antimicrob Agents Chemother (1984) 1.15
Immunology of the lower respiratory tract. Functional properties of bronchoalveolar lymphocytes obtained from the normal canine lung. J Clin Invest (1973) 1.15
Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin. Life Sci (1992) 1.15
The human secondary immune response to Keyhole limpet haemocyanin. Clin Exp Immunol (1972) 1.15